1.9966

1.55% 0.0366

Caribou Biosciences Inc (CRBU)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CRBU Giù? Forum Previsione

Precedente Chiudi:

$1.96

Aprire:

Volume 24 ore:

673.08K

Relative Volume:

0.58

Capitalizzazione di mercato:

$176.12M

Reddito:

$34.48M

Utile/perdita netta:

$-102.07M

Rapporto P/E:

-1.097

EPS:

-1.82

Flusso di cassa netto:

$-104.90M

1 W Prestazione:

-4.77%

1M Prestazione:

+1.03%

6M Prestazione:

-35.59%

1 anno Prestazione:

-62.45%

Intervallo 1D:

$1.91

$2.0389

Intervallo di 1 settimana:

$1.91

$2.12

Portata 52W:

$1.50

$8.33

Caribou Biosciences Inc Stock (CRBU) Company Profile

Nome

Caribou Biosciences Inc

Settore

Healthcare (1195)

Industria

Biotechnology (683)

Telefono

510-982-6030

Indirizzo

2929 7TH STREET, SUITE 105, BERKELEY

Dipendente

137

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

CRBU's Discussions on Twitter

Confronta CRBU con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CRBU	1.995	176.12M	34.48M	-102.07M	-104.90M	-1.82
VRTX	449.09	115.43B	10.63B	-479.80M	-1.35B	13.33
REGN	749.38	82.04B	13.85B	4.65B	3.32B	35.06
ARGX	587.39	35.30B	1.86B	-40.29M	-1.28B	-4.16
ALNY	247.66	32.04B	2.09B	-332.26M	16.06M	-4.14
BNTX	106.77	24.89B	3.30B	-501.07M	1.03B	11.54

Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-07-11	Iniziato	Truist	Buy
2022-02-18	Iniziato	RBC Capital Mkts	Outperform
2021-12-01	Iniziato	Oppenheimer	Outperform
2021-11-30	Iniziato	H.C. Wainwright	Buy
2021-11-15	Aggiornamento	Citigroup	Neutral → Buy
2021-08-17	Iniziato	BofA Securities	Buy
2021-08-17	Iniziato	Citigroup	Neutral
2021-08-17	Iniziato	SVB Leerink	Outperform

Mostra tutto

Caribou Biosciences Inc Borsa (CRBU) Ultime notizie

Nov 20, 2024

Caribou Biosciences to Participate in Upcoming Investor Conferences - The Manila Times

Nov 20, 2024

Caribou Biosciences CEO to Present at Major Healthcare Conferences on CRISPR Advances | CRBU Stock News - StockTitan

Nov 20, 2024

Nov 18, 2024

The Rosen Law Firm, P.A. Announces Proposed Class Action - GlobeNewswire

Nov 18, 2024

The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Caribou Biosciences, Inc. – CRBU - GlobeNewswire Inc.

Nov 18, 2024

Nov 15, 2024

Steven Cohen's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com

Nov 15, 2024

Caribou Biosciences (NASDAQ:CRBU) Receives Buy Rating from HC Wainwright - MarketBeat

Nov 15, 2024

PFM Health Sciences, LP Increases Stake in Caribou Biosciences I - GuruFocus.com

Nov 15, 2024

Nov 13, 2024

Caribou Biosciences' SWOT analysis: biotech stock's potential amid clinical trials - Investing.com Australia

Nov 13, 2024

Nov 12, 2024

Caribou Biosciences, Inc. (NASDAQ:CRBU) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance

Nov 10, 2024

Nov 09, 2024

Caribou Biosciences (NASDAQ:CRBU) Announces Quarterly Earnings Results - MarketBeat

Nov 09, 2024

Caribou Biosciences (NASDAQ:CRBU) vs. Sutro Biopharma (NASDAQ:STRO) Financial Analysis - Defense World

Nov 09, 2024

Nov 08, 2024

Caribou Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 08, 2024

Nov 06, 2024

Caribou Biosciences earnings beat by $0.07, revenue fell short of estimates - Investing.com UK

Nov 06, 2024

Caribou Biosciences reports Q3 EPS (38c), consensus (45c) - TipRanks

Nov 06, 2024

Caribou Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update - StockTitan

Nov 06, 2024

CRISPR Technology Market Report 2024, with Profiles of Major Players Agilent Technologies, Beam Therapeutics, Caribou Biosciences, Crispr Therapeutics, Danaher, Genscript, Lonza and MoreResearchAndMarkets.com | FinancialContent Business Page - Financial Content

Nov 06, 2024

Nov 05, 2024

Caribou Biosciences, Inc.'s (NASDAQ:CRBU) Shares Bounce 25% But Its Business Still Trails The Industry - Simply Wall St

Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com

Nov 05, 2024

Nov 03, 2024

Critical Analysis: Caribou Biosciences (NASDAQ:CRBU) & Titan Pharmaceuticals (NASDAQ:TTNP) - Defense World

Nov 03, 2024

Oct 31, 2024

Is Caribou Biosciences (CRBU) a Promising Gene Editing Stock? - Insider Monkey

Oct 31, 2024

Oct 30, 2024

10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds - Insider Monkey

Oct 30, 2024

Oct 22, 2024

Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Bought by Exchange Traded Concepts LLC - Defense World

Oct 22, 2024

Oct 17, 2024

STATE STREET CORP's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com

Oct 17, 2024

Following a 49% decline over last year, recent gains may please Caribou Biosciences, Inc. (NASDAQ:CRBU) institutional owners - Simply Wall St

Oct 17, 2024

Oct 16, 2024

Its Stock Has Paid Off Big Time For Caribou Biosciences Inc - SETE News

Oct 16, 2024

Oct 15, 2024

How to interpret Caribou Biosciences Inc (CRBU)’s stock chart patterns - US Post News

Oct 15, 2024

Oct 14, 2024

Daily Market Movement: Caribou Biosciences Inc (CRBU) Sees a 5.56 Increase, Closing at 1.90 - The Dwinnex

Oct 14, 2024

Oct 10, 2024

Dimensional Fund Advisors LP Has $4.30 Million Stock Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - MarketBeat

Oct 10, 2024

Oct 09, 2024

A better buy-in window may exist right now for Caribou Biosciences Inc (CRBU) - SETE News

Oct 09, 2024

Oct 08, 2024

Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Purchased by Green Alpha Advisors LLC - Defense World

Oct 08, 2024